Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Nilsson, D; Nyholm, D; Aquilonius, SM
   Duodenal levodopa infusion in Parkinson's disease - long-term experience
   ACTA NEUROLOGICA SCANDINAVICA
   
   D. Nilsson et al., "Duodenal levodopa infusion in Parkinson's disease - long-term experience", ACT NEUR SC, 104(6), 2001, pp. 343-348
2. Stacy, M
   Pharmacotherapy for advanced Parkinson's disease
   PHARMACOTHERAPY
   
   M. Stacy, "Pharmacotherapy for advanced Parkinson's disease", PHARMACOTHE, 20(1), 2000, pp. 8S-16S
3. Alegret, M; Vendrell, P; Junque, C; Valldeoriola, F; Nobbe, FA; Rumia, J; Tolosa, E
   Effects of unilateral posteroventral pallidotomy on 'on-off' cognitive fluctuations in Parkinson's disease
   NEUROPSYCHOLOGIA
   
   M. Alegret et al., "Effects of unilateral posteroventral pallidotomy on 'on-off' cognitive fluctuations in Parkinson's disease", NEUROPSYCHO, 38(5), 2000, pp. 628-633
4. Colosimo, C; De Michele, M
   Motor fluctuations in Parkinson's disease: pathophysiology and treatment
   EUROPEAN JOURNAL OF NEUROLOGY
   
   C. Colosimo e M. De Michele, "Motor fluctuations in Parkinson's disease: pathophysiology and treatment", EUR J NEUR, 6(1), 1999, pp. 1-21
5. LANGE KW
   CLINICAL-PHARMACOLOGY OF DOPAMINE AGONISTS IN PARKINSONS-DISEASE
   Drugs & aging
   
   K.W. Lange, "CLINICAL-PHARMACOLOGY OF DOPAMINE AGONISTS IN PARKINSONS-DISEASE", Drugs & aging, 13(5), 1998, pp. 381-389
6. SYED N; MURPHY J; ZIMMERMAN T; MARK MH; SAGE JI
   10 YEARS EXPERIENCE WITH ENTERAL LEVODOPA INFUSIONS FOR MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE
   Movement disorders
   
   N. Syed et al., "10 YEARS EXPERIENCE WITH ENTERAL LEVODOPA INFUSIONS FOR MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE", Movement disorders, 13(2), 1998, pp. 336-338
7. BAAS H; HARDER S; BURKLIN F; DEMISCH L; FISCHER PA
   PHARMACODYNAMICS OF LEVODOPA COADMINISTERED WITH APOMORPHINE IN PARKINSONIAN-PATIENTS WITH END-OF-DOSE MOTOR FLUCTUATIONS
   Clinical neuropharmacology
   
   H. Baas et al., "PHARMACODYNAMICS OF LEVODOPA COADMINISTERED WITH APOMORPHINE IN PARKINSONIAN-PATIENTS WITH END-OF-DOSE MOTOR FLUCTUATIONS", Clinical neuropharmacology, 21(2), 1998, pp. 86-92
8. TOLOSA E; MARTI MJ; VALLDEORIOLA F; MOLINUEVO JL
   HISTORY OF LEVODOPA AND DOPAMINE AGONISTS IN PARKINSONS-DISEASE TREATMENT
   Neurology
   
   E. Tolosa et al., "HISTORY OF LEVODOPA AND DOPAMINE AGONISTS IN PARKINSONS-DISEASE TREATMENT", Neurology, 50(6), 1998, pp. 2-10
9. FURUYA R; HIRAI A; ANDOH T; KUDOH I; OKUMURA F
   SUCCESSFUL PERIOPERATIVE MANAGEMENT OF A PATIENT WITH PARKINSONS-DISEASE BY ENTERAL LEVODOPA ADMINISTRATION UNDER PROPOFOL ANESTHESIA
   Anesthesiology
   
   R. Furuya et al., "SUCCESSFUL PERIOPERATIVE MANAGEMENT OF A PATIENT WITH PARKINSONS-DISEASE BY ENTERAL LEVODOPA ADMINISTRATION UNDER PROPOFOL ANESTHESIA", Anesthesiology, 89(1), 1998, pp. 261-263
10. KURTH MC
    USING LIQUID LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE - A PRACTICAL GUIDE
    Drugs & aging
    
    M.C. Kurth, "USING LIQUID LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE - A PRACTICAL GUIDE", Drugs & aging, 10(5), 1997, pp. 332-340
11. UGWOKE MI; VERBEKE N; KINGET R
    MICROENCAPSULATION OF APOMORPHINE HCL WITH GELATIN
    International journal of pharmaceutics
    
    M.I. Ugwoke et al., "MICROENCAPSULATION OF APOMORPHINE HCL WITH GELATIN", International journal of pharmaceutics, 148(1), 1997, pp. 23-32
12. MERELLO M; PIKIELNY R; CAMMAROTA A; LEIGUARDA R
    COMPARISON OF SUBCUTANEOUS APOMORPHINE VERSUS DISPERSIBLE MADOPAR LATENCY AND EFFECT DURATION IN PARKINSONS-DISEASE PATIENTS - A DOUBLE-BLIND SINGLE-DOSE STUDY
    Clinical neuropharmacology
    
    M. Merello et al., "COMPARISON OF SUBCUTANEOUS APOMORPHINE VERSUS DISPERSIBLE MADOPAR LATENCY AND EFFECT DURATION IN PARKINSONS-DISEASE PATIENTS - A DOUBLE-BLIND SINGLE-DOSE STUDY", Clinical neuropharmacology, 20(2), 1997, pp. 165-167
13. HUGHES AJ
    DRUG-TREATMENT OF PARKINSONS-DISEASE IN THE 1990S - ACHIEVEMENTS AND FUTURE POSSIBILITIES
    Drugs
    
    A.J. Hughes, "DRUG-TREATMENT OF PARKINSONS-DISEASE IN THE 1990S - ACHIEVEMENTS AND FUTURE POSSIBILITIES", Drugs, 53(2), 1997, pp. 195-205
14. DJALDETTI R; MELAMED E
    LEVODOPA ETHYLESTER - A NOVEL RESCUE THERAPY FOR RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE
    Annals of neurology
    
    R. Djaldetti e E. Melamed, "LEVODOPA ETHYLESTER - A NOVEL RESCUE THERAPY FOR RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE", Annals of neurology, 39(3), 1996, pp. 400-404
15. CONTIN M; RIVA R; ALBANI F; BARUZZI A
    PHARMACOKINETIC OPTIMIZATION IN THE TREATMENT OF PARKINSONS-DISEASE
    Clinical pharmacokinetics
    
    M. Contin et al., "PHARMACOKINETIC OPTIMIZATION IN THE TREATMENT OF PARKINSONS-DISEASE", Clinical pharmacokinetics, 30(6), 1996, pp. 463-481
16. DJALDETTI R; ZIV I; MELAMED E
    IMPAIRED ABSORPTION OF ORAL LEVODOPA - A MAJOR CAUSE FOR RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE
    Israel journal of medical sciences
    
    R. Djaldetti et al., "IMPAIRED ABSORPTION OF ORAL LEVODOPA - A MAJOR CAUSE FOR RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE", Israel journal of medical sciences, 32(12), 1996, pp. 1224-1227
17. CORBOY DL; WAGNER ML; SAGE JI
    APOMORPHINE FOR MOTOR FLUCTUATIONS AND FREEZING IN PARKINSONS-DISEASE
    The Annals of pharmacotherapy
    
    D.L. Corboy et al., "APOMORPHINE FOR MOTOR FLUCTUATIONS AND FREEZING IN PARKINSONS-DISEASE", The Annals of pharmacotherapy, 29(3), 1995, pp. 282-288
18. ASHRAF W; WSZOLEK ZK; PFEIFFER RF; NORMAND M; MAURER K; SRB F; EDWARDS LL; QUIGLEY EMM
    ANORECTAL FUNCTION IN FLUCTUATING (ON-OFF) PARKINSONS-DISEASE - EVALUATION BY COMBINED ANORECTAL MANOMETRY AND ELECTROMYOGRAPHY
    Movement disorders
    
    W. Ashraf et al., "ANORECTAL FUNCTION IN FLUCTUATING (ON-OFF) PARKINSONS-DISEASE - EVALUATION BY COMBINED ANORECTAL MANOMETRY AND ELECTROMYOGRAPHY", Movement disorders, 10(5), 1995, pp. 650-657
19. MUGUET D; BROUSSOLLE E; CHAZOT G
    APOMORPHINE IN PATIENTS WITH PARKINSONS-DISEASE
    Biomedicine & pharmacotherapy
    
    D. Muguet et al., "APOMORPHINE IN PATIENTS WITH PARKINSONS-DISEASE", Biomedicine & pharmacotherapy, 49(4), 1995, pp. 197-209
20. BREDBERG E; LENNERNAS H; PAALZOW L
    PHARMACOKINETICS OF LEVODOPA AND CARBIDOPA IN RATS FOLLOWING DIFFERENT ROUTES OF ADMINISTRATION
    Pharmaceutical research
    
    E. Bredberg et al., "PHARMACOKINETICS OF LEVODOPA AND CARBIDOPA IN RATS FOLLOWING DIFFERENT ROUTES OF ADMINISTRATION", Pharmaceutical research, 11(4), 1994, pp. 549-555
21. COLOSIMO C; MERELLO M; ALBANESE A
    CLINICAL USEFULNESS OF APOMORPHINE IN MOVEMENT-DISORDERS
    Clinical neuropharmacology
    
    C. Colosimo et al., "CLINICAL USEFULNESS OF APOMORPHINE IN MOVEMENT-DISORDERS", Clinical neuropharmacology, 17(3), 1994, pp. 243-259
22. MANYAM BV; SHONKWILER S
    STANDARD CARBIDOPA-LEVODOPA VERSUS CONTROLLED-RELEASE CARBIDOPA-LEVODOPA IN PARKINSONS-DISEASE - A POSTMARKET ANALYSIS
    Clinical neuropharmacology
    
    B.V. Manyam e S. Shonkwiler, "STANDARD CARBIDOPA-LEVODOPA VERSUS CONTROLLED-RELEASE CARBIDOPA-LEVODOPA IN PARKINSONS-DISEASE - A POSTMARKET ANALYSIS", Clinical neuropharmacology, 17(2), 1994, pp. 128-137
23. CHERON G; PIETTE T; THIRIAUX A; JACQUY J; GODAUX E
    SOMATOSENSORY-EVOKED POTENTIALS AT REST AND DURING MOVEMENT IN PARKINSONS-DISEASE - EVIDENCE FOR A SPECIFIC APOMORPHINE EFFECT ON THE FRONTAL N30 WAVE
    Electroencephalography and clinical neurophysiology
    
    G. Cheron et al., "SOMATOSENSORY-EVOKED POTENTIALS AT REST AND DURING MOVEMENT IN PARKINSONS-DISEASE - EVIDENCE FOR A SPECIFIC APOMORPHINE EFFECT ON THE FRONTAL N30 WAVE", Electroencephalography and clinical neurophysiology, 92(6), 1994, pp. 491-501
24. COPELAND LG; DUTTON J; ROBERTS NB; PLAYFER JR
    ROUTINE OUTPATIENT L-DOPA MONITORING IN ELDERLY PATIENTS WITH PARKINSONS-DISEASE
    Age and ageing
    
    L.G. Copeland et al., "ROUTINE OUTPATIENT L-DOPA MONITORING IN ELDERLY PATIENTS WITH PARKINSONS-DISEASE", Age and ageing, 23(2), 1994, pp. 138-141
25. PIRTOSEK Z; MERELLO M; CARLSSON A; STERN G
    PRECLAMOL AND PARKINSONIAN FLUCTUATIONS
    Clinical neuropharmacology
    
    Z. Pirtosek et al., "PRECLAMOL AND PARKINSONIAN FLUCTUATIONS", Clinical neuropharmacology, 16(6), 1993, pp. 550-554
26. ROOS RAC; TIJSSEN MAJ; VANDERVELDE EA; BREIMER DD
    THE INFLUENCE OF A STANDARD MEAL ON SINEMET CR ABSORPTION IN PATIENTSWITH PARKINSONS-DISEASE
    Clinical neurology and neurosurgery
    
    R.A.C. Roos et al., "THE INFLUENCE OF A STANDARD MEAL ON SINEMET CR ABSORPTION IN PATIENTSWITH PARKINSONS-DISEASE", Clinical neurology and neurosurgery, 95(3), 1993, pp. 215-219
27. PINTER MM; HELSCHER RJ; SATTLER AP
    APOMORPHINE TEST IN IDIOPATHIC PARKINSONI AN SYNDROME-DOSAGE AND CORRESPONDING PARAMETERS
    Wiener Klinische Wochenschrift
    
    M.M. Pinter et al., "APOMORPHINE TEST IN IDIOPATHIC PARKINSONI AN SYNDROME-DOSAGE AND CORRESPONDING PARAMETERS", Wiener Klinische Wochenschrift, 105(16), 1993, pp. 472-475
28. LEWITT PA
    LEVODOPA THERAPEUTICS - NEW TREATMENT STRATEGIES
    Neurology
    
    P.A. Lewitt, "LEVODOPA THERAPEUTICS - NEW TREATMENT STRATEGIES", Neurology, 43(12), 1993, pp. 31-37
29. MAUGUIERE F; BROUSSOLLE E; ISNARD J
    APOMORPHINE-INDUCED RELIEF OF THE AKINETIC-RIGID SYNDROME AND EARLY MEDIAN NERVE SOMATOSENSORY-EVOKED POTENTIALS (SEPS) IN PARKINSONS-DISEASE
    Electroencephalography and clinical neurophysiology
    
    F. Mauguiere et al., "APOMORPHINE-INDUCED RELIEF OF THE AKINETIC-RIGID SYNDROME AND EARLY MEDIAN NERVE SOMATOSENSORY-EVOKED POTENTIALS (SEPS) IN PARKINSONS-DISEASE", Electroencephalography and clinical neurophysiology, 88(4), 1993, pp. 243-254